These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37942754)

  • 1. Effect of exercise intervention on clinical parameters in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.
    Zeng Y; Zhang X; Luo W; Sheng Y
    Eur J Gastroenterol Hepatol; 2024 Jan; 36(1):1-12. PubMed ID: 37942754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Wang ST; Zheng J; Peng HW; Cai XL; Pan XT; Li HQ; Hong QZ; Peng XE
    BMC Gastroenterol; 2020 Mar; 20(1):66. PubMed ID: 32164541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive Effects of Exercise Intervention without Weight Loss and Dietary Changes in NAFLD-Related Clinical Parameters: A Systematic Review and Meta-Analysis.
    Babu AF; Csader S; Lok J; Gómez-Gallego C; Hanhineva K; El-Nezami H; Schwab U
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review.
    Nie Q; Li M; Huang C; Yuan Y; Liang Q; Ma X; Qiu T; Li J
    J Transl Med; 2024 Mar; 22(1):225. PubMed ID: 38429794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic outcome of dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Hu C; Qu T; Li L; Huang Y; Liu H; Rao C
    Afr Health Sci; 2023 Jun; 23(2):416-421. PubMed ID: 38223613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of glucagon-like peptide-1 receptor agonists on fat accumulation in patients with diabetes mellitus and non-alcoholic fatty liver disease or obesity: A systematic review and meta-analysis of randomized control trials.
    Xie W; Hong Z; Li B; Huang B; Dong S; Cai Y; Ruan L; Xu Q; Mou L; Zhang Y
    J Diabetes Complications; 2024 Jun; 38(6):108743. PubMed ID: 38688179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis.
    Li S; Duan F; Li S; Lu B
    Ann Hepatol; 2024; 29(2):101174. PubMed ID: 38579127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
    Front Immunol; 2022; 13():949746. PubMed ID: 36159792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis.
    Katsagoni CN; Georgoulis M; Papatheodoridis GV; Panagiotakos DB; Kontogianni MD
    Metabolism; 2017 Mar; 68():119-132. PubMed ID: 28183444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four kinds of traditional Chinese exercise therapy in the treatment of type 2 diabetes: a systematic review and network meta-analysis.
    Jia Y; Huang H; Yu Y; Jia H; Zhang Y
    Syst Rev; 2023 Dec; 12(1):231. PubMed ID: 38093392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Zhu Y; Xu J; Zhang D; Mu X; Shi Y; Chen S; Wu Z; Li S
    Front Endocrinol (Lausanne); 2021; 12():769069. PubMed ID: 34956080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of fecal microbiota transplantation in type 2 diabetes mellitus: a systematic review and meta-analysis.
    Yang Y; Yan J; Li S; Liu M; Han R; Wang Y; Wang Z; Wang D
    Endocrine; 2024 Apr; 84(1):48-62. PubMed ID: 38001323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acupuncture for type 2 diabetes mellitus with nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis.
    Li M; Yao L; Huang H; Wang G; Yu B; Zheng H; Wang H
    Medicine (Baltimore); 2021 May; 100(21):e26043. PubMed ID: 34032730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of glucagon-like peptide-1 receptor agonists on glycemic control and anthropometric profiles among diabetic patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Nowrouzi-Sohrabi P; Rezaei S; Jalali M; Ashourpour M; Ahmadipour A; Keshavarz P; Akbari H
    Eur J Pharmacol; 2021 Feb; 893():173823. PubMed ID: 33352183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of Huanglian Wendan decoction in treating type 2 diabetes mellitus: A systematic review and meta-analysis.
    Tian Y; Pang G; Pan L
    Medicine (Baltimore); 2023 Oct; 102(40):e35299. PubMed ID: 37800822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of Chinese herbal medicine as an add-on therapy for type 2 diabetes mellitus patients with carotid atherosclerosis: An updated meta-analysis of 27 randomized controlled trials.
    Zhang Z; Leng Y; Chen Z; Fu X; Liang Q; Peng X; Xie H; Gao H; Xie C
    Front Pharmacol; 2023; 14():1091718. PubMed ID: 37033624
    [No Abstract]   [Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationship between Prebiotic Supplementation and Anthropometric and Biochemical Parameters in Patients with NAFLD-A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Stachowska E; Portincasa P; Jamioł-Milc D; Maciejewska-Markiewicz D; Skonieczna-Żydecka K
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33187278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis.
    Houttu V; Bouts J; Vali Y; Daams J; Grefhorst A; Nieuwdorp M; Holleboom AG
    Front Endocrinol (Lausanne); 2022; 13():1032164. PubMed ID: 36407307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Different Exercise Methods on Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression.
    Xiong Y; Peng Q; Cao C; Xu Z; Zhang B
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33801028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.